University of Kansas Medical Center announces nearly $27 million NIH grant to accelerate clinical and translational research in the region

KANSAS CITY, KANSAS (September 21, 2022) – The University of Kansas Medical Center today announced a five-year, nearly $27 million grant from the National Institutes of Health that will fund Frontiers Clinical and Translational Science Institute at the University of Kansas. While this grant is awarded to the University of Kansas and administered through KU Medical Center, it represents a far-reaching regional initiative with principal investigators at both KU Medical Center and Children’s Mercy Kansas City.
“The University of Kansas is proud to celebrate this accomplishment,” said Douglas A. Girod, M.D., chancellor of the University of Kansas. “The impact of this grant goes far beyond its direct funding, impacting the entire region with the power of its partnerships, collaborations and innovations. This work helps ensure KU is ahead of the curve nationally.”
The institute is part of a network of 62 such hubs nationwide that are funded with a grant from the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health. Frontiers accelerates research by connecting scientists to resources; facilitating collaboration among researchers, communities and institutions; and offering training.
Girod also noted the Clinical and Translational Science Award (CTSA) propelled KU into a unique class. “KU is one of only 28 U.S. universities with a cancer center, Alzheimer’s disease research center and a clinical and translational science institute, all recognized with a national designation by appropriate agencies within the National Institutes of Health,” he said.
Robert D. Simari, M.D., executive vice chancellor at KU Medical Center, noted that the work of Frontiers has become even more collaborative with this latest grant renewal, providing researchers from many different institutions with additional opportunities to collaborate, connect and solve complex problems.
“One of our primary missions is to encourage discovery and collaboration to find treatments and cures to benefit the health of Kansans and beyond,” Simari said. “This NCATS award will ensure continued growth and acceleration of our research efforts by embracing partners throughout the region.”
Mario Castro, M.D., MPH, co-principal investigator on the Frontiers grant and vice chair for clinical and translational research in the Department of Internal Medicine at KU School of Medicine, noted that Frontiers is well positioned to begin its next chapter. “We are excited to launch the next phase of our Frontiers Clinical and Translational Science Institute, where we have expanded our partnerships to address the clinical and translational research needs of those living in Kansas and western Missouri,” he said. “Frontiers fosters research that is innovative and cutting-edge. We strive to improve health care and to achieve health equity for our patients, especially the underserved and historically excluded, including those in rural locations.”
For the first time in Frontier’s history, its work will be jointly led. “I am excited to work with Dr. Castro and all members of the broad Frontiers community to achieve our goal of accelerating the development of research discoveries into improved diagnostic and treatment options for the patients, families and communities that we serve,” said J. Steven Leeder, Pharm.D., Ph.D., co-principal investigator on the Frontiers grant and deputy director of the Children’s Mercy Research Institute. “It is our intent for Frontiers to become the academic home for investigators engaged in all forms of clinical and translational research at our partner institutions to identify and break down barriers and improve better health outcomes for all.”
While the principal investigators are at KU Medical Center and Children’s Mercy, other partners include Kansas City University, the University of Kansas, Kansas State University, the University of Missouri-Kansas City, Saint Luke’s Health System and The University of Kansas Health System. An additional up to $12 million in funding will be provided by the partners as they support the work of Frontiers at their own institutions.
Frontiers will be having an event Sept. 23 at the World War I Museum and Memorial, from 4:30 p.m. to 8 p.m., to celebrate. Media are welcome. Contact frontiers-info@kumc.edu to RSVP.
# # #
About Frontiers Clinical and Translational Science Institute at the University of Kansas
The Frontiers Clinical and Translational Sciences Institute at the University of Kansas is a regional initiative involving academic institutions, health care systems and community organizations that addresses the clinical and translational research needs of Kansas and western Missouri. Frontiers supports high-quality translational science and clinical research locally, regionally and nationally. It fosters innovation in research methods, training and career development of investigators committed to improving health and achieving health equity across the lifespan, with a focus on underserved and excluded populations. Supported by a five-year, $27 million grant from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH), Frontiers is part of a
network of 62 such hubs nationwide that work to speed the research process from scientific discovery to patient care.
About the University of Kansas Medical Center:
The University of Kansas Medical Center’s mission is to educate exceptional health care professionals through a full range of undergraduate, graduate, professional, postdoctoral and continuing education programs in the schools of Medicine, Nursing and Health Professions. KU Medical Center also advances the health sciences through world-class research programs; provides compassionate and state-of-the-art patient care in an academic medical center environment; and works with communities in every Kansas county to improve the health of Kansans.